Arch Biopartners Inc V.ARCH

Alternate Symbol(s): ACHFF

Technology Scientific & Technical Instruments

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is LSALT Peptide. The Company is engaged in the clinical development of LSALT Peptide and other DPEP-1 targeting drug candidates for indications where inflammation of the lungs, liver and kidneys is an unmet problem. LSALT Peptide is in a second phase II trial, targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The Company has additional technology platforms in its portfolio, which are AB569 and Borg. AB569 is an anti-infective candidate for treating or preventing antibiotic resistant bacterial infections, primarily as a topical treatment for wounds.

TSXV:ARCH - Post by User

Arch Biopartners Inc

<< Previous

Bullboard Posts

Next >>

Post by Riverfolkon Nov 05, 2021 4:22pm

117 Views

Post# 34094135

This Weeks House Positions

House Positions for C:ARCH from 20211101 to 20211105

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
22 Fidelity	165,800	509,342	3.072	11,200	33,918	3.028	154,600	-475,424
9 BMO Nesbitt	77,800	244,713	3.145	25,600	80,748	3.154	52,200	-163,965
124 Questrade	16,611	52,926	3.186	4,635	13,808	2.979	11,976	-39,118
85 Scotia	13,834	43,394	3.137	3,566	10,844	3.041	10,268	-32,550
14 ITG	9,354	26,970	2.883	1,173	3,698	3.153	8,181	-23,272
33 Canaccord	11,200	34,830	3.11	4,400	12,883	2.928	6,800	-21,947
13 Instinet	9,900	29,208	2.95	5,500	17,789	3.234	4,400	-11,419
88 Credential	4,000	12,700	3.175	100	320	3.20	3,900	-12,380
89 Raymond James	1,900	5,909	3.11	0			1,900	-5,909
72 Credit Suisse	1,000	3,309	3.309	0			1,000	-3,309
28 BBS	23	75	3.261	0			23	-75
84 Ind Trading	50	154	3.08	67	201	3.00	-17	47
68 Leede	1,532	4,806	3.137	1,568	4,929	3.143	-36	123
53 Morgan Stanley	13	43	3.308	82	240	2.927	-69	197
83 Mackie	0			250	764	3.056	-250	764
2 RBC	33,275	99,277	2.984	35,320	110,935	3.141	-2,045	11,658
39 Merrill Lynch	50	160	3.20	2,450	7,546	3.08	-2,400	7,386
74 GMP	0			3,800	11,772	3.098	-3,800	11,772
80 National Bank	8,738	27,499	3.147	19,118	59,282	3.101	-10,380	31,783
7 TD Sec	97,551	299,091	3.066	123,552	386,402	3.127	-26,001	87,311
79 CIBC	40,524	126,568	3.123	70,309	217,705	3.096	-29,785	91,137
1 Anonymous	228,785	699,662	3.058	409,250	1,246,855	3.047	-180,465	547,193
TOTAL	721,940	2,220,636	3.076	721,940	2,220,639	3.076	0	3